These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 21170987)

  • 1. Polo-like kinase 1 regulates cell proliferation and is targeted by miR-593* in esophageal cancer.
    Ito T; Sato F; Kan T; Cheng Y; David S; Agarwal R; Paun BC; Jin Z; Olaru AV; Hamilton JP; Selaru FM; Yang J; Matsumura N; Shimizu K; Abraham JM; Shimada Y; Mori Y; Meltzer SJ
    Int J Cancer; 2011 Nov; 129(9):2134-46. PubMed ID: 21170987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.
    Liu J; Lu KH; Liu ZL; Sun M; De W; Wang ZX
    BMC Cancer; 2012 Nov; 12():519. PubMed ID: 23151088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-296-5p suppresses papillary thyroid carcinoma cell growth via targeting PLK1.
    Zhou SL; Tang QL; Zhou SX; Ren RZ
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2084-2091. PubMed ID: 30915753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of PLK1 through competition between hnRNPK, miR-149-3p and miR-193b-5p.
    Shin CH; Lee H; Kim HR; Choi KH; Joung JG; Kim HH
    Cell Death Differ; 2017 Nov; 24(11):1861-1871. PubMed ID: 28708135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-296-5p suppresses cell viability by directly targeting PLK1 in non-small cell lung cancer.
    Xu C; Li S; Chen T; Hu H; Ding C; Xu Z; Chen J; Liu Z; Lei Z; Zhang HT; Li C; Zhao J
    Oncol Rep; 2016 Jan; 35(1):497-503. PubMed ID: 26549165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. lncRNA CCAT1 is a biomarker for the proliferation and drug resistance of esophageal cancer via the miR-143/PLK1/BUBR1 axis.
    Hu M; Zhang Q; Tian XH; Wang JL; Niu YX; Li G
    Mol Carcinog; 2019 Dec; 58(12):2207-2217. PubMed ID: 31544294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA miR-509 Regulates ERK1/2, the Vimentin Network, and Focal Adhesions by Targeting Plk1.
    Liao G; Wang R; Rezey AC; Gerlach BD; Tang DD
    Sci Rep; 2018 Aug; 8(1):12635. PubMed ID: 30135525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-509-3-5p causes aberrant mitosis and anti-proliferative effect by suppression of PLK1 in human lung cancer A549 cells.
    Wang XH; Lu Y; Liang JJ; Cao JX; Jin YQ; An GS; Ni JH; Jia HT; Li SY
    Biochem Biophys Res Commun; 2016 Sep; 478(2):676-82. PubMed ID: 27498003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
    Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
    Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-545 suppresses progression of ovarian cancer through mediating PLK1 expression by a direct binding and an indirect regulation involving KDM4B-mediated demethylation.
    Zhang H; Zhang K; Xu Z; Chen Z; Wang Q; Wang C; Cui J
    BMC Cancer; 2021 Feb; 21(1):163. PubMed ID: 33588776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hsa-let-7b inhibits cell proliferation by targeting PLK1 in HCC.
    He Z; Deng W; Jiang B; Liu S; Tang M; Liu Y; Zhang J
    Gene; 2018 Oct; 673():46-55. PubMed ID: 29913237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A miR-361-5p/ ORC6/ PLK1 axis regulates prostate cancer progression.
    Liu Z; Zhang Y; Yu L; Zhang Z; Li G
    Exp Cell Res; 2024 Jul; 440(1):114130. PubMed ID: 38885805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR‑210 regulates esophageal cancer cell proliferation by inducing G2/M phase cell cycle arrest through targeting PLK1.
    Li C; Zhou X; Wang Y; Jing S; Yang C; Sun G; Liu Q; Cheng Y; Wang L
    Mol Med Rep; 2014 Oct; 10(4):2099-104. PubMed ID: 25069478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA TUG1 promotes esophageal cancer development through regulating PLK1 expression by sponging miR-1294.
    Zong M; Feng W; Wan L; Yu X; Yu W
    Biotechnol Lett; 2020 Dec; 42(12):2537-2549. PubMed ID: 33009634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [miR-593 inhibits proliferation of colon cancer cells
    Ma J; Zhu Y; Wang Z; Zan J; Cao L; Feng Z; Wang S; Fan Q; Yan L
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Feb; 39(2):144-149. PubMed ID: 30890500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polo-like kinase 1, a new therapeutic target in hepatocellular carcinoma.
    Mok WC; Wasser S; Tan T; Lim SG
    World J Gastroenterol; 2012 Jul; 18(27):3527-36. PubMed ID: 22826617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of polo-like kinase (Plk) 1 via siRNA causes inhibition of growth and induction of apoptosis in human esophageal cancer cells.
    Bu Y; Yang Z; Li Q; Song F
    Oncology; 2008; 74(3-4):198-206. PubMed ID: 18714168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polo-like kinase 1 is overexpressed in colorectal cancer and participates in the migration and invasion of colorectal cancer cells.
    Han DP; Zhu QL; Cui JT; Wang PX; Qu S; Cao QF; Zong YP; Feng B; Zheng MH; Lu AG
    Med Sci Monit; 2012 Jun; 18(6):BR237-46. PubMed ID: 22648245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer.
    Shi W; Alajez NM; Bastianutto C; Hui AB; Mocanu JD; Ito E; Busson P; Lo KW; Ng R; Waldron J; O'Sullivan B; Liu FF
    Int J Cancer; 2010 May; 126(9):2036-48. PubMed ID: 19739117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 3'UTR polymorphism modulates mRNA stability of the oncogene and drug target Polo-like Kinase 1.
    Akdeli N; Riemann K; Westphal J; Hess J; Siffert W; Bachmann HS
    Mol Cancer; 2014 Apr; 13():87. PubMed ID: 24767679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.